TITLE:
A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)

CONDITION:
Measles

INTERVENTION:
Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live

SUMMARY:

      The purpose of this study is to determine the mumps virus strength at the end of shelf-life
      (expiration date) of an approved vaccine.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 12 Months to 18 Months
Criteria:

        Inclusion Criteria:

          -  Healthy children 12 to 18 months of age

        Exclusion Criteria:

          -  History or prior exposure to measles, mumps, rubella or varicella

          -  History of anaphylactoid reactions or hypersensitivity to any component of the
             vaccine, including gelatin and neomycin
      
